Abstract

In this study, we report the isolation and identification of an endophytic strain of Burkholderia cepacia (COPS strain) associated with Polygala paniculata roots. Polygala plants are rich sources of promising microbiomes, of which the literature reports several pharmacological effects, such as trypanocidal, antinociceptive, anesthetic, anxiolytics, and anticonvulsant activities. B. cepacia COPS belongs to a new sequence type (ST 1870) and harbors a genome estimated in 8.3 Mbp which exhibits the aminoglycosides and beta-lactams resistance genes aph(3′)-IIa and blaTEM-116, respectively. Analysis performed using MLST, average nucleotide identity, and digital DNA-DNA hybridization support its species-level identification and reveals its novel housekeeping genes alleles gyrB, lepA, and phaC. The root endophyte B. cepacia COPS drew our attention from a group of 14 bacterial isolates during the primary screening for being potentially active against Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, Micrococcus luteus ATCC 9341, Escherichia coli ATCC 25922, and Candida albicans ATCC 10231 and exhibited the broad-spectrum activity against phytopathogenic fungi. In addition, COPS strain showed production of protease, lipase, and esterase in solid media, and its natural product extract showed potent inhibition against fungal plant pathogens, such as Moniliophthora perniciosa, whose antagonism index (89.32%) exceeded the positive control (74.17%), whereas Sclerotinia sclerotiorum and Ceratocystis paradoxa showed high percentages of inhibition (85.53% and 82.69%, respectively). COPS crude extract also significantly inhibited S. epidermidis ATCC 35984, E. faecium ATCC 700221 (MIC values of 32 μg/mL for both), E. faecalis ATCC 29212 (64 μg/mL), and S. aureus ATCC 25923 (128 μg/mL). We observed moderate antagonistic activity against A. baumannii ATCC 19606 and E. coli ATCC 25922 (both at 512 μg/mL), as well as potent cytotoxic effects on Leishmania infantum and Leishmania major promastigote forms with 78.25% and 57.30% inhibition. In conclusion, this study presents for the first time the isolation of an endophytic B. cepacia strain associated with P. paniculata and enough evidence that these plants may be considered a rich source of microbes for the fight against neglected diseases.

Highlights

  • Plant tissues represent a significant source of natural substances for pharmaceutical and biotechnological interest

  • Endophytes are capable to biosynthesize a plethora of natural products and compounds which are originally believed to be produced only by their host plants [4, 5], and they are considered alternative suppliers of characteristic phytochemical compounds and represent a vast unexplored reservoir of unique chemical structures [6]. ese plant-symbiont microorganisms that live in intimate interaction establish a mutualistic interaction with the host plant by exchanging nutrients and protection; they produce antibiotics and other substances that can protect the plant against stress conditions such as attack by herbivores, pests, and plant pathogens without causing apparent disease symptoms [7,8,9]

  • We aimed to explore the endophytes of Polygala paniculata and isolate antibiotic- and biotechnology-related enzymes-producing microorganisms

Read more

Summary

Introduction

Plant tissues represent a significant source of natural substances for pharmaceutical and biotechnological interest. Polygala paniculata (commonly known as “mimosa,” “barba-de-bode,” “barba-de-São-João,” and “vassourinha branca”) is a medicinal plant that frequently grows on the Brazilian coast and is used in traditional medicine due to their analgesic properties and treatment of inflammatory diseases such as asthma, bronchitis, arthritis, and disorders of the kidney [10,11,12]. Plants within this genus are well-known producers of a variety of phytochemical compounds [13], such as methyl salicylate, alkaloids [14], xanthones [15, 16], saponins [17, 18], coumarins [11, 19], and styrylpyrones [11]. The exploitation of medicinal plants’ microbiome, which produces bioactive metabolites, is fundamental [31, 32]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.